Don’t buy or sell Royal Mail plc, British American Tobacco plc or Johnson Service Group plc until you’ve read this

Could these 3 stocks be about to fall in value? Royal Mail plc (LON: RMG), British American Tobacco plc (LON: BATS) and Johnson Service Group plc (LON: JSG).

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The tobacco industry is currently going through its biggest change in a generation. That’s because new lower-risk products are becoming increasingly popular, with e-cigarettes being the most obvious example of changing consumer habits. And with the e-cigarette market being worth billions and growing at a rapid rate, it could provide a turbo boost to the earnings of British American Tobacco (LSE: BATS).

Certainly, British American Tobacco is being hurt by falling cigarette volumes. This is the same for the entire industry, but with tobacco companies having tremendous pricing power they’re able to offset volume declines with price rises. Looking ahead, this situation looks set to continue over the medium-to-long term and when combined with the potential for growth within the e-cigarette and reduced risk segment, British American Tobacco’s earnings have a bright future.

With the company trading on a price-to-earnings (P/E) ratio of 17.7, it seems to offer good value for money given its growth prospects and excellent defensive profile. Therefore, buying British American Tobacco right now could be a sound move.

Should you invest £1,000 in British American Tobacco right now?

When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets. And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if British American Tobacco made the list?

See the 6 stocks

Sound long-term buy

Similarly, Royal Mail (LSE: RMG) has significant future potential. Like British American Tobacco, one aspect of its business is struggling but this is set to be offset by strength elsewhere. So while Royal Mail’s letters business continues to offer a challenging long-term future, its European operations offer upbeat growth prospects.

Furthermore, Royal Mail trades on a relatively attractive valuation which indicates that it offers a generous margin of safety. For example, it has a P/E ratio of just 12.9 and this indicates that there’s upward rerating potential. And with Royal Mail having a yield of 4.5%, it remains a very enticing income play.

Certainly, there’s work for management to do in terms of making the business more efficient and improving its near-term performance, but for long-term investors it remains a sound buy.

Scope for rising dividends

Meanwhile, textile services specialist Johnson Service Group (LSE: JSG) has had an excellent recent period with its shares rising by 481% in the last five years. During this time the business has made significant changes and this seems to have paid off, with double-digit growth in earnings being recorded in each of the last three years.

Looking ahead, further growth of 9% is forecast for the current year, with 10% growth being pencilled-in by the market for next year. This puts Johnson Service Group on a price-to-earnings growth (PEG) ratio of only 1.3, which indicates that there’s capital gain potential on the cards. And with Johnson Service Group paying out only a third of profit as a dividend, there seems to be considerable scope for a rise in the company’s 2.3% yield.

Should you invest £1,000 in British American Tobacco right now?

When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets.

And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if British American Tobacco made the list?

See the 6 stocks

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Peter Stephens owns shares of British American Tobacco and Royal Mail. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Close-up image depicting a woman in her 70s taking British bank notes from her colourful leather wallet.
Investing Articles

£10,000 invested in Tesco shares just a fortnight ago is already worth…

Tesco shares went through a sharp wobble a couple of weeks ago, but here's a look at what's happened to…

Read more »

Young female analyst working at her desk in the office
Investing Articles

9.6% yield! Here’s the dividend forecast for Glencore shares to 2027!

At nearly 10%, Glencore shares have one of the largest dividend yields on the FTSE 100. Here's why they could…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing Articles

£20,000 Stocks and Shares ISA: how long would it take to reach £1 million?

This writer considers how long it would take an investor to reach a seven-figure sum by maxing out their Stocks…

Read more »

British flag, Big Ben, Houses of Parliament and British flag composition
Investing Articles

UK bonds: a once-in-a-decade passive income opportunity?

Gilts are offering some very attractive yields at the moment. But Stephen Wright thinks passive income investors could still do…

Read more »

Frustrated young white male looking disconsolate while sat on his sofa holding a beer
Investing Articles

Down 99%, this stock has been crushed by AI and is now a penny share!

Chegg has gone from being a fast-growth tech stock to a penny share trading for less than $1 in the…

Read more »

Young Asian man drinking coffee at home and looking at his phone
Investing Articles

Could this rapidly growing coffee stock be the next Warren Buffett-style winner?

Discover why a fast-growing US coffee chain could be the next big US growth stock, with similarities to stocks picked…

Read more »

Woman riding her old fashioned bicycle along the Beach Esplanade at Aberdeen, Scotland.
Investing Articles

2 high-yielding dividend stocks I continue to double down on

Andrew Mackie explores two FTSE 350 high-yielding dividend stocks he's been snapping up in the last few weeks for his…

Read more »

Stack of British pound coins falling on list of share prices
Investing Articles

Why did the AstraZeneca share price just fall, and what should we do?

The AstraZeneca share price just took a hit as President Trump announced a price war against the US pharmaceutical industry.

Read more »